See more : Daybreak Oil and Gas, Inc. (DBRM) Income Statement Analysis – Financial Results
Complete financial analysis of CaliPharms, Inc. (KGET) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of CaliPharms, Inc., a leading company in the Agricultural Inputs industry within the Basic Materials sector.
- Kingsoft Cloud Holdings Limited (3896.HK) Income Statement Analysis – Financial Results
- KOTON MAGAZACILIK (KOTON.IS) Income Statement Analysis – Financial Results
- Jiangsu Recbio Technology Co., Ltd. (2179.HK) Income Statement Analysis – Financial Results
- MeiraGTx Holdings plc (MGTX) Income Statement Analysis – Financial Results
- Dateline Resources Limited (DTR.AX) Income Statement Analysis – Financial Results
CaliPharms, Inc. (KGET)
About CaliPharms, Inc.
CaliPharms, Inc. engages in the medicinal Cannabis Industry in the United States. It focuses on the THC and CBD beverage industry. The company was formerly known as Kleangas Energy Technologies, Inc. and changed its name to CaliPharms, Inc. in January, 2017. CaliPharms, Inc. is based in Temecula, California.
| Metric | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2013 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.00K | 0.00 | 0.00 | 0.00 |
| Cost of Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Gross Profit | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 12.00K | 0.00 | 0.00 | 0.00 |
| Gross Profit Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 100.00% | 0.00% | 0.00% | 0.00% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Selling & Marketing | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 357.86K | 340.28K | 184.18K |
| Other Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Operating Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 357.86K | 340.28K | 184.18K |
| Cost & Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 1.36M | 357.86K | 340.28K | 184.18K |
| Interest Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Interest Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 76.65K | 83.73K | 618.35K | 144.55K |
| Depreciation & Amortization | 228.49K | 236.56K | 206.30K | 171.86K | 161.14K | 52.52K | 22.82K | 0.00 | 0.00 |
| EBITDA | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.35M | -357.86K | -340.28K | -184.18K |
| EBITDA Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11,222.67% | 0.00% | 0.00% | 0.00% |
| Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.35M | -357.86K | -340.28K | -184.18K |
| Operating Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11,222.67% | 0.00% | 0.00% | 0.00% |
| Total Other Income/Expenses | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -76.65K | -83.73K | -618.35K | 183.97K |
| Income Before Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.42M | -441.59K | -958.63K | -213.25K |
| Income Before Tax Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11,861.40% | 0.00% | 0.00% | 0.00% |
| Income Tax Expense | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | -1.42M | -441.59K | -958.63K | -213.25K |
| Net Income Ratio | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -11,861.40% | 0.00% | 0.00% | 0.00% |
| EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Weighted Avg Shares Out | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.78B | 6.46B | 6.35B | 2.26B |
| Weighted Avg Shares Out (Dil) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 10.78B | 6.46B | 6.35B | 2.26B |
Source: https://incomestatements.info
Category: Stock Reports